Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
To evaluate if a combination therapy with micropulse diode laser (MPL) shows non-inferiority on visual acuity (BCVA) within 12 months in comparison to standard therapy, i.e. intravitreal injection of ranibizum...
Source: BMC Ophthalmology - Category: Opthalmology Authors: Olga Furashova, Patrick Strassburger, Klio Ai Becker and Katrin Engelmann Tags: Research article Source Type: research
More News: Clinical Trials | Diabetes | Endocrinology | Lucentis | Opthalmology | Ranibizumab Injection